Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$469M |
| 2 |
Amazon
AMZN
|
+$373M |
| 3 |
Microsoft
MSFT
|
+$308M |
| 4 |
Netflix
NFLX
|
+$195M |
| 5 |
NVIDIA
NVDA
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$675M |
| 2 |
COOP
Mr. Cooper
COOP
|
+$430M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
| 4 |
ExxonMobil
XOM
|
+$383M |
| 5 |
IPG
Interpublic Group of Companies
IPG
|
+$203M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.93% |
| 2 | Financials | 18.11% |
| 3 | Industrials | 12.13% |
| 4 | Consumer Discretionary | 10.34% |
| 5 | Healthcare | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Champions Oncology
CSBR
$72.1M
| $175K | ﹤0.01% |
25,354
+1,652
| +7% | +$11K |
|
3102
Eledon Pharmaceuticals
ELDN
$285M
| $175K | ﹤0.01% |
115,682
-19,079
| -14% | -$45.4K |
|
3103
Traeger
COOK
$172M
| $169K | ﹤0.01% |
3,129
-3,949
| -56% | -$192K |
|
|
KZR
3104
DELISTED
Kezar Life Sciences
KZR
| $167K | ﹤0.01% |
26,543
+3,312
| +14% | +$19.3K |
|
3105
Cineverse
CNVS
$65.6M
| $166K | ﹤0.01% |
78,936
+8,155
| +12% | +$22.1K |
|
3106
Rapid Micro Biosystems
RPID
$86.2M
| $162K | ﹤0.01% |
56,182
+540
| +1% | +$1.88K |
|
3107
Senseonics Holdings Inc
SENS
$366M
| $160K | ﹤0.01% |
+29,069
| New | +$202K |
|
3108
Exagen
XGN
$166M
| $160K | ﹤0.01% |
26,358
-1,029
| -4% | -$9.37K |
|
3109
Rocky Mountain Chocolate Factory
RMCF
$7.84M
| $160K | ﹤0.01% |
84,184
-14,612
| -15% | -$24.3K |
|
3110
Cosan
CSAN
$2.84B
| $158K | ﹤0.01% |
40,000
-6,100
| -13% | -$27.8K |
|
3111
Cardiff Oncology
CRDF
$77.2M
| $157K | ﹤0.01% |
55,710
+12
| +0% | +$28 |
|
3112
Quest Resource Holding
QRHC
$31.6M
| $155K | ﹤0.01% |
83,204
-135,933
| -62% | -$230K |
|
|
FIRY
3113
Firy Inc
FIRY
$163M
| $150K | ﹤0.01% |
34,771
+9,402
| +37% | +$58.1K |
|
|
LGCY
3114
Legacy Education Inc
LGCY
$145M
| $149K | ﹤0.01% |
+14,651
| New | +$141K |
|
3115
Pliant Therapeutics
PLRX
$65M
| $149K | ﹤0.01% |
121,756
-29,917
| -20% | -$44.9K |
|
3116
Cardlytics
CDLX
$21.5M
| $146K | ﹤0.01% |
12,723
-8,120
| -39% | -$125K |
|
3117
Southland Holdings
SLND
$31.4M
| $145K | ﹤0.01% |
43,815
+17,888
| +69% | +$70.5K |
|
3118
Lightbridge
LTBR
$311M
| $144K | ﹤0.01% |
11,391
-5,633
| -33% | -$108K |
|
3119
Harte-Hanks
HHS
| $138K | ﹤0.01% |
45,988
| – | – |
|
3120
Vince Holding Corp
VNCE
$86.8M
| $135K | ﹤0.01% |
+33,133
| New | +$102K |
|
3121
NovaGold Resources
NG
$3.33B
| $135K | ﹤0.01% |
14,490
| – | – |
|
|
SRG
3122
Seritage Growth Properties
SRG
$136M
| $132K | ﹤0.01% |
40,618
+7,271
| +22% | +$27.6K |
|
3123
Zentalis Pharmaceuticals
ZNTL
$302M
| $130K | ﹤0.01% |
96,263
-88,769
| -48% | -$129K |
|
3124
US Global Investors
GROW
$38.5M
| $129K | ﹤0.01% |
53,644
-2,862
| -5% | -$7.12K |
|
3125
Immuneering
IMRX
$292M
| $129K | ﹤0.01% |
19,562
| – | – |
|
Similar funds
Dimensional Fund Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Dimensional Fund Advisors held 3,340 positions worth $477B, up 2.3% from $466B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Dimensional Fund Advisors's Q4 2025 filing shows 69 new, 1,594 increased, 1,516 reduced and 100 closed positions. Its largest new stake was Qnity Electronics Inc: 1,613,007 shares worth $132M. The largest sale was Alphabet (Google) Class C, an estimated $675M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q4 2025 buy was Qnity Electronics Inc: 1,613,007 shares worth $132M.
- Dimensional Fund Advisors added most to Meta Platforms (Facebook) in Q4 2025, an estimated $469M increase.
- Dimensional Fund Advisors's biggest Q4 2025 reduction was Alphabet (Google) Class C, cutting an estimated $675M.
- Dimensional Fund Advisors fully exited Mr. Cooper in Q4 2025, selling an estimated $430M.
- Dimensional Fund Advisors's ten largest holdings make up 18% of its $477B portfolio in Q4 2025.
- Dimensional Fund Advisors opened 69 new positions and closed 100 in Q4 2025.
- Dimensional Fund Advisors's portfolio value rose 2.3% quarter-over-quarter to $477B.
Based on Dimensional Fund Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.